Home | FCA & regulatory news | British English edition
Trade Hub UK

Independent coverage of UK markets, FCA policy and institutional trading
AD Bank of England Statistics AD Investing.com Markets AD LSEG Data AD CME Group Education
Venues & MTFs

Recursion Pharma Q3 Net Loss Narrows, Reports Positive REC-4881 Data; Advances Pipeline

City noticeboard, Trade Hub UK (2026-11-03): Recursion Pharma Q3 Net Loss Narrows, Reports Positive REC-4881 Data; Advances Pipeline (RTTNews) - Recursion Pharmaceuticals, Inc. (RXRX), a clinical-stage… Primary source: original at Nasdaq Market Structure (nasdaq.com).

By Nasdaq Market Structure

Recursion Pharma Q3 Net Loss Narrows, Reports Positive REC-4881 Data; Advances Pipeline

(RTTNews) - Recursion Pharmaceuticals, Inc. (RXRX), a clinical-stage company pioneering AI-enabled drug discovery and development, reported third-quarter results ended September 30, 2026, reflecting a narrower net loss, positive REC-4881 data in familial adenomatous polyposis (FA

Read at source

Read also
  1. MPLX Reports Earnings on Nov. 3, 2026. Here's What Investors Should Be Watching.
  2. Forget U.S. Rescheduling: Tilray's 71% Growth in Europe Is the Story Investors Are Missing
  3. Ceconomy AG - Depositary Receipt Price Target Increased by 16.19% to $0.93
  4. Stellantis Stock Is Soaring. Europe Is Crashing the Party.
  5. Bavarian Nordic Awarded 4 Year Mpox And Smallpox Vaccine Supply Contract By UK Government

Source: Nasdaq Market Structure